ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2016
[Impact of cytomegalovirus intestinal disease on the prognosis in patients with severe intestinal graft- versus- host disease].
Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore risk factors, clinical characteristics and prognosis of CMV enteritis combined with severe intestinal graft- versus- host disease (GVHD).
methodsThe data of 80 intestinal grade Ⅲ/Ⅳ GVHD patients from January 2005 to September 2015 in hematology of PKUPH were retrospectively analyzed. All patients received colonoscopy and all GVHD diagnoses were based on clinical manifestation, colonoscopy and biopsies. All patients were divided into biopsy- proven CMV enteritis and control groups. Various characteristics, clinical manifestation and transplantation related mortality were compared.
resultsA total of 18 patients were diagnosed with biopsy- proven CMV enteritis, including 14 antigens positive, 2 inclusion bodies positive (1 positive for both antigen and inclusion body) and 3 intestinal mucosa CMV PCR positive. The median diagnosis time for CMV enteritis was 65 days (range, 27 to 278 days) after transplantation. There was no statistically difference for baseline (age, gender, underlying disease, status of disease, et al) between two groups. The NRM between CMV enteritis and control groups was significantly different (61.1% vs. 33.9%,P=0.044).
conclusionCMV enteritis was a risk factor of NRM for grade Ⅲ/Ⅳ intestinal GVHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.